In 2022, Hendrix Genetics announced the appointment of Richard Maatman as deputy chief executive officer (CEO) of Hendrix Genetics and mentioned that Richard would succeed Antoon van den Berg as CEO in the course of 2023.
After a successful introduction and transition period, Antoon van den Berg has decided to step down from his position as CEO and chairman of the Executive Committee of Hendrix Genetics. As of April 1, 2023, he will hand over his responsibilities to Richard Maatman. Antoon will remain an actively involved shareholder in our company.
With this change, the executive committee will consist of four members:
- Chief Executive Officer and chairman: Richard Maatman
- Chief Business Development Officer: Raf Beeren
- Chief Financial Officer: Roger van Biljouw
- Chief Innovation & Technology Officer: Johan van Arendonk
Maatman has extensive international management experience in agribusiness, animal breeding and animal nutrition. After graduating from Wageningen Agriculture University in 1993, where he obtained a master’s degree in animal science with specialization in animal breeding, he joined Nutreco/Euribrid as geneticist of Hisex Layers. From 1998-2000, he worked as a geneticist for Hendrix Poultry Breeders, the predecessor of Hendrix Genetics. From 2003-2007, he was general manager of the broiler breeding activities Hybro which was combined in 2008 with Cobb-Vantress. Maatman held from 2007-2022 various senior management positions within Nutreco. In his most recent role as managing director, he was leading the Trouw Nutrition activities for Europe, Central-Asia and Middle East. Maatman joined Hendrix Genetics as deputy CEO at the beginning of January this year.
In 2005, Antoon van den Berg and Thijs Hendrix founded Hendrix Genetics, a leading multi-species animal genetics and technology company that provides the animal protein value chain with innovative and sustainable genetic solutions to support the global food challenge.
In March 2022, a joint venture with Paine Schwartz and its affiliated co-investors that own 50% in the company was announced. Hendrix Genetics’ Co-Founders Thijs Hendrix and Antoon van den Berg also maintain a 50% ownership position in the Company and work in partnership with Paine Schwartz.